RNA-targeting compounds or small interfering RNAs (siRNAs) offer a potent means for controlling viral infections. An essential prerequisite to their design depends on identifying conserved and ...

HONG KONG SAR - Media OutReach Newswire - 20 December 2024 - AIM Vaccine (06660.HK) has added good news to the research and ...

In this manuscript, Yao et al. present solid evidence to show that MnMYL3 may serve as a receptor for NNV via macropinocytosis. This manuscript is valuable for understanding the molecular mechanisms ...

Aethlon Medical (AEMD) provided a statement of its investigational medical device with respect to H5N1 avian influenza “Bird Flu.” The company ...

SAN DIEGO - December 20, 2024 (Investorideas.com Newswire) Aethlon Medical, Inc. ( Nasdaq: AEMD ), a medical therapeutic ...

Cell and gene therapies are revolutionizing medicine. Looking to 2025, advancements in allogeneic therapies, streamlined ...

Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and ...

Whatever you’d call it, 2024 was a wild ride on the pop culture rollercoaster. From a “missing” princess to a viral hippo to ...

Almost 75 years ago, a doctor at Johns Hopkins Hospital in Baltimore cultured the first immortal cell line that could be ...

The stock has had big gains in this morning's trading session following an update on the company's Hemopurifier device in the treatment of Bird Flu. The stock is trading at $0.5761, up 0.1427, gaining ...

From a total solar eclipse that captivated our continent to record temperatures that scorched the planet, these were the ...

Nearly 70 government officials, farmers and farmworkers, and researchers with expertise in virology, pandemics and more weigh ...